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Hepatitis C virus (HCV) infection is a causative factor leading to hepatocellular carcinoma
due to chronic inflammation and cirrhosis. The aim of the study was first to explore
the effects of grape seed extract (GSE) in HCV replication, and then to study
mechanisms. The results indicated that a GSE treatment showed significant anti-
HCV activity and suppressed HCV-elevated cyclooxygenase-2 (COX-2) expression. In
contrast, exogenous COX-2 expression gradually attenuated antiviral effects of GSE,
suggesting that GSE inhibited HCV replication by suppressing an aberrant COX-2
expression caused by HCV, which was correlated with the inactivation of IKK-regulated
NF-κB and MAPK/ERK/JNK signaling pathways. In addition, GSE also attenuated HCV-
induced inflammatory cytokine gene expression. Notably, a combined administration of
GSE with interferon or other FDA-approved antiviral drugs revealed a synergistic anti-
HCV effect. Collectively, these findings demonstrate the possibility of developing GSE
as a dietary supplement to treat patients with a chronic HCV infection.
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INTRODUCTION
Chronic hepatitis C caused by hepatitis C virus (HCV) infection is strongly associated with
the progression of liver disease, including cirrhosis and hepatocellular carcinoma (HCC), by
inducing chronic liver inflammation (Kwon et al., 2014). Till date, more than 170 million
people are chronically infected with HCV. HCV is an enveloped, positive-sense single-
stranded RNA virus belonging to the Flaviviridae family. HCV genomic RNA encodes a
polyprotein that is then cleaved by both host and virus protease into 10 mature proteins (core,
glycoprotein E1, and E2) and non-structural proteins (NS2, NS3, NS6A, NS4B, NS5A, and
NS5B). Among these proteins, core and NS5A have been suggested as potentially oncogenic
proteins contributing to the development of HCC during chronic HCV infection because of
long-term activation of various pro-inflammatory cytokines and chemokines, such as tumor
necrosis factor (TNF-α), interleukin-1 (IL-1), inducible nitric oxide synthase (iNOS), and
cyclooxygenase-2 (COX-2) (Banerjee et al., 2010). To date, there is no vaccine available to
prevent HCV infection. Until recently, three direct-acting antiviral (DAA) agents targeting
HCV protease or polymerase, including telaprevir, boceprevir, and sofosbuvir, have already been
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approved to treat HCV infection alone or in combination with
current standard-of-care therapy using pegylated interferon-alfa
plus ribavirin (Koretz, 2014). Although, the sustained virologic
response (SVR) rate is improved with the use of these agents, the
side effects profile, DAA-resistance mutations, and even the high
cost frequently interfere with their therapeutic effect (Sarrazin
and Zeuzem, 2010). Thus, efforts to screen molecules that focus
on new therapeutic targets are still required.
Cyclooxygenase-2 is an important pro-inflammatory
mediator that responses to diverse inflammatory stimuli such as
a 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment or a
virus infection (Kim et al., 2010; Radi et al., 2010; Chen et al.,
2015). The prostaglandins converted from arachidonic acid
by COX-2 have been reported to enhance tumor growth and
angiogenesis in various tumors (Chang et al., 2004; Tveteraas
et al., 2012). The aberrant expression of COX-2 observed in
chronic hepatitis C patients was associated with an increased
risk of HCC (Bae et al., 2001). As mentioned earlier, the HCV
protein greatly stimulated COX-2 expression and in turn, COX-2
overexpression enhanced HCV replication (Chen et al., 2015).
Because of these observations, our previous studies have proved
that several natural products can effectively suppress HCV
replication by inhibiting NF-kB-mediated COX-2 expression,
which supported targeting the COX-2 signaling pathway as a
promising approach to develop therapeutic or chemopreventive
agents against HCV-positive HCC formation (Lee et al., 2011;
Lin et al., 2013).
Grape seed extract (GSE) has been widely used as dietary
supplement because of its many bioactivity properties,
including antioxidant, hepatoprotective, neuroprotective,
cardioprotective, anticancer, anti-inflammation, antiaging, and
antimicrobial effects (Bagchi et al., 2014; Olaku et al., 2015).
GSE contains large amount of phenolic compounds, including
gallic acid, (+)-catechin, epicatechin, dimeric procyanidin, and
proanthocyanidins that are suggested to be the major bioactive
components against many diseases (Shi et al., 2003). GSE has
also been reported to exhibit an antiviral activity against human
immunodeficiency virus type 1 (Nair et al., 2002), human
enteric virus, human norovirus surrogates [feline calicivirus
(FCV) F9 and murine norovirus (MNV-19)] (Su and D’Souza,
2011), and hepatitis A virus (Joshi et al., 2015), although the
antiviral action was different and also not sufficiently studied.
To date, its effect on HCV is undefined. Here, we assess the
biological effect and molecular action of GSE on anti-HCV
replication and anti-HCV-induced inflammation. Notably,
the effect of combined treatment of GSE and the anti-HCV
drugs currently used in a clinical setting were further assessed,
which provides great clinical and economic significance for
the supplemental treatment for HCV infection and its related
diseases.
MATERIALS AND METHODS
Cell Culture and Reagents
Huh-7 cells, the human hepatoma cell, and Ava5 cell, the Huh-
7 cells harboring HCV genotype 1b subgenomic RNA replicon
(Blight et al., 2000), were used for antiviral studies. Both were
maintained in Dulbecco’s modified Eagle’s medium with 10%
heat-inactivated fetal bovine serum, 1% antibiotic-antimycotic,
and 1% non-essential amino acids. All cells were incubated at
37◦C with a 5% CO2 supplement. The IH636 GSE was purchased
from InterHealth Nutraceuticals (Benicia, CA, USA) (Shi et al.,
2003). Interferon α-2a (Roferon©-A) was purchased from Roche,
Ltd. Telaprevir was purchased from Legend Stat International,
Co., Ltd, and daclatasvir and sofosbuvir were purchased from
Shanghai Haoyuan Chemexpress, Co., Ltd. The anti-HCV agents
were prepared as stock solution at 100 mM in 100% DMSO.
The final concentration of DMSO in the all experiments was
constantly maintained at 0.1%. All chemicals were diluted by
DMEM medium.
Western Blotting Assay
The standard procedure of Western blotting was performed as
described previously (Lee et al., 2011). The membranes were
probed with monoclonal antibodies specific for HCV NS5B
(1:5000; Abcam, Cambridge, MA, USA), glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (1:10000; GeneTex, Irvine,
CA, USA), anti-COX-2 antibody (1:1000; Cayman, MI, USA),
anti-MAPK (phosphorylated and unphosphorylated forms of
ERK1/2, p38, and JNK), anti-IKKα, anti-phospho-IKKα/β
(Ser176/180), anti-NF-κB, anti-IκB-α, anti-phospho-
IκB-α (Ser32) (1:1000; Cell Signaling Technology, Inc.,
Danvers, MA, USA), or anti-C-Myc antibody (1:1000;
GeneTex, Irvine, CA, USA). The ECL detection kit was
used for the signal detection (PerkinElmer, Shelton, CT,
USA).
Quantitative Real-Time RT-PCR
(qRT-PCR) Analysis
The total RNA of the cells were isolated with a total
RNA miniprep purification kit (GMbiolab, Co., Ltd, Taiwan),
according to the manufacturer’s instructions. The cDNA
synthesis was performed by M-MLV Reverse Transcriptase
(Promega, Madison, WI, USA), according to the manufacturer’s
instructions. The levels of HCV NS5B, TNF-α, IL-1β, iNOS,
and COX-2 RNA were detected by RT-qPCR with the following
forward and reverse primer sets: NS5B (AJ238799), 5′-GGA AAC
CAA GCT GCC CAT CA-3′ and 5′-CCT CCA CGG ATA GAA
GTT TA-3′; TNF-α (NM_000594), 5′-CCT GTG AGG AGG
ACG AAC-3′ and 5′-AAG TGG TGG TCT TGT TGC-3′; IL-
1β (NM_000576), 5′-GGA GAA TGA CCT GAG CAC-3′ and
5′-GAC CAG ACA TCA CCA AGC-3′; iNOS (NM_000625),
5′-CTT TGG TGC TGT ATT TCC-3′ and 5′-TGT GAC CTC
AGA TAA TGC-3′; and COX-2 (NM_000963), 5′-CCG AGG
TGT ATG TAT GAG-3′ and 5′-TGG GTA AGT ATG TAG
TGC-3′. The relative RNA level of these genes in each sample
were normalized to cellular GAPDH mRNA with the forward
primer: 5′-GTC TTC ACC ACC ATG GAG AA-3′ and reverse
primer: 5′-ATG GCA TGG ACT GTG GTC AT-3′. The relative
expression levels were analyzed by the ABI Step One Real-
Time PCR-System in the standard procedure (ABI Warrington,
UK).
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Cytotoxicity Assay
The relative cell viabilities were determined by the CellTiter
96 R© AQueous One Solution Cell Proliferation Assay (MTS)
assay that depended on the measurement of mitochondria
dehydrogenase enzyme activity from viable cells (Promega
Corporation, Madison, WI, USA). Ava5 cells at the density
of 5 × 103 per well were treated with GSE at different
concentrations. After a 3-day incubation, the supernatant was
removed and added to the MTS mixture with 100 µl of phenol
red-free medium and 20 µl of the MTS reagent at 37◦C. After
4 h, the relative cell viabilities were analyzed by measuring the
absorption at 490 nm on a microplate reader.
HCV JFH-1 Infection Assay
The cell culture-produced HCV (HCVcc) were generated by the
transfection of in vitro transcribed full-length JFH-1 RNA into
Huh-7.5 (Kato et al., 2006). The Huh-7 cells with a density
of 5 × 104 per well were infected with JFH-1 HCVcc at a
multiplicity of infection (MOI) of 0.1 for 8 h. At the end
of infection, the supernatant was removed and the cells were
incubated with various concentrations of GSE for an additional
3 days. The total RNA of the cells was isolated and the relative
HCV RNA levels were analyzed by a Step One Real-Time PCR-
System.
Synergy Analysis Synergistic
Isobologram
Ava5 cells were incubated in a mixture containing GSE (0, 2.5,
5, 10, and 20 µg/ml) in combination with each of the anti-HCV
agents, IFN-α (0, 7.5, 15, 30, and 60 U/ml), HCV NS3/4A protease
inhibitor telaprevir (0, 0.075, 0.15, 0.3, and 0.6 µM), HCV NS5A
inhibitor daclatasvir (0, 1, 2, 4, and 8 pM), and the RNA-
dependent RNA polymerase nucleoside inhibitor sofosbuvir (0,
10, 20, 40, and 80 nM). After 3 days, the relative HCV RNA
levels were analyzed by a Step One Real-Time PCR-System for
calculating the drug dose effects. Based on the method of Chou
and Talalay (1984), the combination index (CI) was calculated by
CalcuSyn software (Biosoft, Cambridge, UK) with the presence
of synergism (CI < 1), additivity (CI = 1), and antagonism
(CI > 1).
Plasmid Construction
The inactive COX-2 mutant (S516Q) expression vector
(pCMV-COX-2mut-Myc) without cyclooxygenase activity were
generated from pCMV-COX-2-Myc with the primers: forward:
5′-GTTGGAGCACCATTCCAGTTGAAAGGACTTATG-3′,
reverse: 5′-CATAAGTCCTTTCAACTGGAATGGTGCTCCAAC-
3′ by QuikChange R© Site-Directed Mutagenesis Kit according
to the manufacturer’s protocol (Stratagene, La Jolla, CA, USA)
as previous described (Lecomte et al., 1994). All of the DNA
fragments were confirmed by DNA sequencing.
Transient Transfection and Luciferase
Activity Assay
All the transfection reactions were performed with a T-ProTM
reagent (Ji-Feng Biotechnology, Co., Ltd, Taiwan), in accordance
with the manufacturer’s instructions. The Ava5 cells with a
density of 5× 104 per well were transfected with pCOX-2-Luc or
pNF-κB-Luc (BD Biosciences Clontech, Palo Alto, CA, USA) for
8 h. After the transfection procedure, the medium was replaced
with various concentrations of GSE for 3 days. The luciferase
assay was performed using the Bright-GloTM Luciferase Assay
System (Promega) according to the manufacturer’s protocol with
cell extracts from each sample. To identify COX-2 regulation by
GSE, Ava5 cells were transfected with indicated concentrations
of the COX-2 expression vector (pCMV-COX-2-Myc) from 0.5 to
2 µg, and then treated with GSE for additional 3 days. To evaluate
the effect of GSE on viral-induced inflammation response, the
parental Huh-7 cells were infected with the JFH-1 virus for 8 h or
transfected with HCV core or NS5A expression vector (pCMV-
Core-Myc; pCMV-NS5A-Myc) for 12 h, followed by incubation
with or without GSE (5 and 20 µg/ml) for another 3 days. To
determine the effect of GSE on virus-induced inflammatory genes
(TNF-α, IL-1β, iNOS, and COX-2), Huh7 cells were infected with
JFH-1 or transfected with pCMV-Core-Myc or pCMV-NS5A-
Myc in the presence of GSE for 3 days. Subsequently, the total
RNA of the cells was isolated and the relative inflammation
cytokine RNA levels were analyzed by a Step One Real-Time
PCR-System.
Intracellular Prostaglandin E2 (PGE2)
Measurements
Ava5 or Huh7 cells were treated with GSE at various
concentrations for 3 days. Subsequently, the treated cells
were washed thoroughly with cold phosphate-buffered saline
(pH 7.4), and intracellular PGE2 was extracted by a lysis
reagent containing C15H34BrN to rupture cell membrane. The
intracellular PGE2 level was measured with the PGE2 enzyme-
linked immunosorbent assay system (Biotrak, Amersham
Bioscience), according to the manufacturers protocol.
Preparation of Nuclear Fraction
Nuclear extracts were prepared using hypotonic [10 mM HEPES,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 10% Nonidet P-40
(pH 7.9)] and high-salt buffer [20 mM HEPES, 1.5 mM MgCl2,
0.2 mM EDTA, 0.6 M KCl, 0.5 mM DTT (pH 7.9)] extraction
as previously described (Abmayr et al., 2006). Briefly, Ava5 cells
with a density of 4 × 105 per well were treated with or without
GSE at the indicated dose. After 3 days of incubation, the cells
were lysed using the ice-cold hypotonic buffer. The cytoplasmic
fraction were separated by centrifugation at 7,000× g for 15 min.
Then, the resulting nuclear pellets were extracted with high-
salt nuclear extraction buffer at 4◦C for 30 min and the nuclear
proteins were collected after centrifugation at 20,000 × g for
15 min, which stored at−80◦C until use. The protease inhibitors
were added to hypotonic buffer and high-salt buffer immediately
before use.
Statistical Analysis
The results are presented as the mean ± SD for of least
three independent experiments. Statistical data comparisons
were analyzed with the Student’s t-test and ANOVA by using
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GraphPad software and ∗P < 0.05 or ∗∗P < 0.01 was considered
statistically significant.
RESULTS
GSE Suppresses HCV Replication
We first examined the anti-HCV activity of GSE using the
HCV subgenomic RNA stably expressing cell line (Ava5). To
this end, Ava5 cells were treated with various concentrations
of GSE for 3 days or 20 µg/ml of GSE for 1–3 days, followed
by Western blotting and qRT-PCR. The cytotoxicity of GSE
was determined using an MTS assay under identical conditions.
We found that GSE significantly inhibited HCV protein
synthesis (Figures 1A,B) and RNA replication (Figure 1C)
in a concentration- and time-dependent manner, and no
significant cytotoxicity was observed. The inhibitory effect of
GSE on HCV replication was also consistently observed in
HCV-infected Huh-7 cells, with an IC50 of 7.5 ± 0.3 µg/ml
(Figure 1D).
GSE Suppresses HCV Replication by
Reducing COX-2 Expression
Previous studies have reported that GSE exhibited a protective
effect against cancer development and inflammation through
the inhibition of the COX-2 signaling pathway (Derry et al.,
2013). Besides, more reports demonstrated that suppression of
HCV-elevated COX-2 expression could effectively block HCV
replication (Trujillo-Murillo et al., 2007; Lee et al., 2011). To
examine whether the anti-HCV activity of GSE correlates with
suppression of the COX-2 expression, we first examined the effect
of GSE on COX-2 expression using COX-2 promoter-driven
reporter assay in GSE-treated Ava5 cells. The results revealed
that GSE gradually decreased the luciferase activity compared
to the parental Huh-7 cells and the GSE-untreated Ava5 cells
(Figure 2A). The similar result were also observed in HCV
infection assay (Supplementary Figure S1A). We next examined
the COX-2 protein synthesis by Western blotting and measured
the intracellular amount of COX-2 metabolite PGE2 using the
PGE2 ELISA assay. Consistent with the COX-2 promoter-based
activity assay, GSE decreased the HCV-elevated COX-2 protein
(Figure 2B) and PGE2 levels (Figure 2C) in a concentration-
dependent manner. To investigate whether suppression of COX-
2 expression contributes to the anti-HCV activity of GSE, we
transfected increasing concentrations of the COX-2 expression
vector pCMV-COX-2-Myc or inactive COX-2 mutant vector
pCMV-COX-2mut-Myc into GSE-treated Ava5 cells followed by
a measurement of HCV protein synthesis and RNA replication
after 3 days. As shown in Figure 2D, an increasing overexpression
of extraneous COX-2-Myc gradually restored HCV protein levels
(lanes 3–5) compared to GSE-untreated (lane 1), GSE-treated
cells alone (lane 2), and GSE-treated cells with extraneous
inactive COX-2-Myc mutant expression (lane 6), indicating that
COX-2 function is essential to support HCV replication. Similar
FIGURE 1 | Grape seed extract (GSE) suppresses hepatitis C virus (HCV) protein synthesis and RNA replication. (A,B) HCV protein expression was
reduced by a GSE treatment in the HCV replicon system. Ava5 cells were treated with GSE at increasing concentrations (0–20 µg/ml) for 3 days (A) or incubated
with a different time course (1–3 days) with 20 µg/ml of GSE (B). A 100 U/ml treatment of IFN-α served as the positive control for anti-HCV activity. HCV protein
synthesis was detected by Western blotting with anti-HCV NS5B and anti-GAPDH antibodies. The GAPDH protein levels showed equal loading of cell lysates. HCV
RNA replication was reduced by a GSE treatment in the HCV (C) replicon and (D) infectious systems. The total RNA of GSE-treated Ava5 cells or JFH-1-infected
cells were extracted and the relative HCV RNA levels were quantified by qRT-PCR. The cellular gapdh mRNA was used as an internal control for the equal loading of
cDNA. Cytotoxicity was detected by the MTS assay, as described in Section “Materials and Methods.” The relative HCV RNA level and cell viability were presented
as percentage changes compared to the GSE-untreated cells which represented 100%. Data are represented as the mean ± SD for three independent experiments.
∗P < 0.05; ∗∗P < 0.01.
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FIGURE 2 | Reduction of COX-2 expression is involved in the inhibitory effect of GSE on HCV replication. (A) COX-2 promoter activity was reduced with a
GSE treatment in a concentration-dependent manner. Ava5 cells were transiently transfected with the reporter vector containing COX-2 promoter, pCOX-2-Luc.
After 8 h transfection, the medium was replaced with indicated concentrations (0–20 µg/ml) of GSE for another 3 days. Subsequently, the extracted lysates of
transfected cells were analyzed by a luciferase assay. The relative COX-2 promoter activity was presented as fold changes compared to parental Huh-7 cells, whose
activity was presented as 1. (B) Ava5 cells were treated with GSE at increasing concentrations for 3 days. The extracted cell lysates were used to analyze protein
expression by Western blotting with anti-COX-2 and anti-GAPDH (loading control) antibodies, respectively. (C) Ava5 cells were treated with an increasing GSE
concentration. After 3 days, the intercellular PGE2 was extracted by the lysis buffer and quantified by the PGE2 enzyme immunoassay system. (D–F) Exogenous
COX-2 overexpression attenuated the anti-HCV activity of GSE in Ava5 cells. Ava5 cells were transfected with indicated amounts of pCMV-COX-2-Myc or
pCMV-COX-2mut-Myc for 8 h. Subsequently, the transfected cells were treated with 20 µg/ml GSE for another 3 days. (D) The extracted cell lysates were used to
analyze the protein expressions by Western blotting with anti-NS5B, anti-Myc, and anti-GAPDH (loading control) antibodies. (E) The extracted total RNA was used to
quantified HCV RNA levels following normalization of cellular gapdh mRNA by qRT-PCR. The relative HCV RNA levels were presented as percentage changes
compared to GSE-untreated/untransfected Ava5 cells, which was considered as 100%. (F) The intercellular PGE2 level were assayed as previous described. Data
are represented as the mean ± SD for three independent experiments. ∗P < 0.05; ∗∗P < 0.01.
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results were obtained from the measuring the HCV RNA level
under identical conditions (Figure 2E). We also observed that
the GSE-reduced-PGE2 level was gradually restored by functional
COX-2 expression, but not by inactive COX-2 mutant expression
(Figure 2F). Taken together, these results revealed that GSE
inhibited HCV replication by suppressing HCV-elevated COX-2
expression.
GSE-Mediated Regulation of NF-kB and
MAPK Pathways Involved in Suppressing
HCV Replication
Both NF-κB and the mitogen-activated protein kinase (MAPK)
signaling pathways are important regulators of COX-2 expression
(Tsatsanis et al., 2006). To investigate whether GSE suppresses
COX-2 expression by interfering with NF-κB activation, we
first performed an NF-κB-mediated transcription reporter assay.
The Ava5 cells were transfected a pNF-κB-Luc reporter plasmid
and then incubated with increasing concentrations of GSE for
3 days. We found that the GSE concentration-dependently
decreased luciferase activity compared to parental Huh-7 cells
and GSE-untreated Ava5 cells (Figure 3A), indicating that GSE
inhibited the HCV-stimulated NF-κB transcriptional activation.
The similar results were also observed in HCV infection assay
(Supplementary Figure S1B). A Western blot analysis further
confirmed that the nuclear translocation of NF-κB p65 subunit
was significantly interfered by GSE at a concentration of 20µg/ml
(Figure 3B). Phosphorylation of IκB by the active phosphorylated
FIGURE 3 | Grape seed extract reduced NF-κB transactivity and MAPK phosphorylation for suppression of COX-2 expression in HCV replicon cells.
(A) GSE reduced NF-κB transactivity in Ava5 cells. Ava5 cells were transiently transfected with pNF-κB-Luc, which contained an NF-κB binding element linked firefly
luciferase reporter gene. The pNF-κB-Luc-transfected cells were treated with 20 µg/ml of GSE for 3 days. Subsequently, the extracted lysates of transfected cells
were analyzed by luciferase activity assay. The relative NF-κB transactivity was presented as fold changes compared to parental Huh-7 cells in which luciferase
activity was presented as 1. The GSE treatment downregulated (B) NF-κB phosphorylation and (C) the HCV-induced NF-κB signaling pathway. Ava5 cells were
treated with GSE in different concentrations (0–20 µg/ml) for 3 days and the nuclear lysates were isolated as described in Section “Materials and Methods.” The
nuclear translocation of NF-κB were analyzed by Western blotting with anti-phospho-p65 and anti-Lamin B (loading control) antibodies. The effects of GSE on
NF-κB regulation were analyzed by Western blotting with various antibodies against IKKα, phospho-IKKα/β, IκB-α, phospho-IκB-α, and GAPDH (loading control).
(D) GSE treatment reduced the phosphorylation level of ERK and JNK. Ava5 cells were treated with 20 µg/ml of GSE and the lysates extracted at the indicated time
points after the treatment. The protein expressions were analyzed by Western blotting with antibodies against MAPK (ERK1/2, p38, and JNK), phospho-MAPK
(p-ERK1/2, p-p38, and p-JNK), and GAPDH (loading control). Data are represented as the mean ± SD for three independent experiments. ∗P < 0.05; ∗∗P < 0.01.
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form of IKKα/β kinase is a key mechanism to control the
nuclear translocation of the free form of NF-κB due to the
ubiquitin-proteasome proteolysis of phospho-IκB (Chen, 2005).
We further examined the effect of GSE on IKKα/β kinase
and IκB phosphorylation in Ava5 cells. The results of Western
blotting showed that GSE suppressed the amount of active
phospho-IKKα/β kinase in a concentration-dependent manner
(Figure 3C, upper panel). The total amount of IKKα or IKKβ
did not change significantly. As expected, the phospho-IκB
level was gradually decreased by GSE. In the meantime, the
amount of unphospho-IκB accumulated (Figure 3C, middle
panel). These results revealed that inactivation of the IKKα/β
kinase was involved in the suppression of NF-κB-mediated
COX-2 expression by a GSE treatment. In addition to the
NF-κB signaling pathway, we next explored the effect of
GSE on the MAPK pathways on the induction of COX-2
expression. Ava5 cells were treated with GSE at 20 µg/ml
for 0–120 min and we then examined the effect of GSE
on the phosphorylation status of the major regulators of
the MAPK signaling pathway, including extracellular regulated
protein kinases 1 and 2 (ERK1/2), p38 kinase, and c-Jun NH2-
protein kinase (JNK). As shown in Figure 3D, GSE suppressed
the amount of phosphor-ERK and phospho-JNK in a time-
dependent manner (upper and middle panels). In contrast, there
was no significant effect on the phospho-p38 protein level in
GSE-treated Ava5 cells compared to the GSE-untreated control
(lower panel). Consistent with the results of replicon system,
GSE significantly suppressed the amount of phosphor-ERK
and phospho-JNK instead of phospho-p38 in HCV infectious
system (Supplementary Figure S2). Taken together, these results
reveal that GSE inhibits HCV replication by blocking NF-κB
and ERK/JNK MAPK signaling pathways to suppress COX-2
expression.
GSE Attenuates Virus-Induced
Pro-inflammation Cytokines
Acute or chronic inflammation is one of the hallmarks to hepatic
injury, viral replication, and HCC development (Sukowati et al.,
2016). HCV core and NS5A protein are known to be risk factors
in the development of HCV-induced chronic inflammation
(Nunez et al., 2004). To examine whether GSE exhibits a
hepatoprotective activity against virus-induced inflammation, we
measured the effect of GSE on the mRNA levels of several
inflammatory mediators, including TNF-α, iNOS, COX-2 and IL-
1 in HCV-infected, HCV core-expressing, or NS5A-expressing
Huh-7 cells by a qRT-PCR analysis. As shown in Figure 4, the
results demonstrated that HCV infection (A), core (B), or the
NS5A (C) protein could transcriptionally activate those of the
inflammatory mediators by approximately five to eightfold as
compared to parental Huh-7 cells. With a GSE treatment, the
mRNA levels of those stimulated pro-inflammatory mediators
were concentration-dependently reduced by GSE compared to
the levels observed in HCV-infected, core or NS5A-transfected
Huh-7 cells with no GSE treatment, revealing that GSE can
be used as a potential hepatoprotective agent against HCV-
stimulated inflammation.
Synergistic Anti-HCV Replication by a
GSE Treatment Combined with Either
IFN-α or Viral Enzyme Inhibitors
To examine the potency of GSE with supplementary usage,
we examined the anti-HCV activity of GSE in combination
with IFN-α or other USA Food Drug Administration (FDA)
approved anti-HCV drugs, including NS3/4A protease inhibitor
telaprevir, NS5A inhibitor daclatasvir, and NS5B polymerase
inhibitor sofosbuvir. Ava5 cells were incubated with GSE and
combined with either IFN-α or other HCV inhibitors at
various fixed concentration ratios. The anti-HCV replication
activities were analyzed by qRT-PCR. The CI values were
calculated by CalcuSynTM software based on the principle
described by Chou and Talalay (Chou and Talalay, 1984). The
drug interaction in terms of synergism, CI < 1 for ED50,
ED75, and ED90 (range: 0.86–0.34) and shown in Table 1,
which indicated that a combination treatment exhibited a
synergistic effect on anti-HCV activity. This means that GSE
could be developed as a useful supplement or adjuvant to
treat patients with chronic HCV infection under a combination
regimen.
DISCUSSION
Grape seed extract (GSE) containing more amounts of flavonoids
have been promoted as a healthy food in our daily diet. It is
a key issue to be resolved for establishing the bioavailability in
in vivo conditions. In the present study, we clearly demonstrated
that GSE exerted inhibitory effects on HCV replication without
causing host cellular toxicity (Figure 1). In the last decade, there
are more than 50% of plant-derived compounds have served
as an important source and being used in clinical practice as
pharmaceuticals for drug development (Cragg and Newman,
2005). Besides, plants are considered as potential sources to
discover new bioactive compounds against HCV infection. In
addition, many natural products show significant cytoprotective
effects in various diseases as well as that GSE have been
TABLE 1 | The CI of a GSE treatment combined with various anti-HCV
agents on anti-HCV replication.
Combination compound CI values at Influence
ED50 ED75 ED90
IFN-α 0.73 0.49 0.38 Synergistic
Telapriver 0.82 0.68 0.56 Synergistic
Daclatasvir 0.86 0.72 0.53 Synergistic
Sofobuvir 0.54 0.43 0.34 Synergistic
Ava5 cells were treated with GSE combined with IFN-α, telaprevir, daclatasvir,
or sofosbuvir in a fixed ratio for 3 days. The combination treatment of anti-HCV
activity was analyzed by qRT-PCR. The CI value for the effective dose of 50%
(ED50), 75% (ED75), or 90% (ED90) inhibition was calculated by using the CalcuSyn
computer program. Results are expressed as the mean± SD for three independent
experiments. The calculated CI values indicated that CI < 1, CI = 1, and CI > 1
represented synergism, additivity, and antagonism on anti-HCV activity between
the two agents, respectively.
Frontiers in Pharmacology | www.frontiersin.org 7 December 2016 | Volume 7 | Article 490
fphar-07-00490 December 19, 2016 Time: 12:27 # 8
Chen et al. GSE Inhibits HCV and Inflammation
FIGURE 4 | Grape seed extract inhibits HCV viral-induced pro-inflammatory cytokine gene expression. A GSE treatment reduced the inflammation
response, which was induced by (A) JFH-1 infection or exogenous overexpression of (B) Core or (C) NS5A. The Huh-7 cells were infected with JFH-1 or transfected
with each HCV viral protein expression vectors (pCMV-NS5A-Myc or pCMV-Core-Myc). Subsequently, the cells were treated with 5 or 20 µg/ml GSE. After 3 days,
the total RNA of the cells was extracted. The inflammation cytokines including TNF-α, IL-1β, iNOS, and COX-2 were quantified with specific primers and normalized
by cellular gapdh mRNA using qRT-PCR. The relative inflammation cytokine expression levels of uninfected/untransfected Huh-7 cell were defined as 1. Data are
represented as the mean ± SD for three independent experiments. ∗P < 0.05; ∗∗P < 0.01.
studied and showed significant effects in many disease, including
cancer, inflammation, and even infectious diseases. Comparable
with present study, there are several compounds which have
significant antioxidant activity against HCV infection, such
as curcumin, silymarin, silibinin, and epigallocatechin-3-gallate
(EGCG) (Chen C. et al., 2012; Chen M.H. et al., 2012; Polyak
et al., 2013). According to the significant antioxidant activity
and popular in dietary supplement of GSE, we suggested that
GSE may serve as a potential anti-viral adjuvant for HCV
patients.
Grape seed extract contains a high amount of
proanthocyanidins, which have been isolated from blueberry
leaves and shown to inhibit HCV replication by binding to
host heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1
(Takeshita et al., 2009). Although, the precise mechanism
of binding hnRNPs by proanthocyanidin to suppress HCV
replication was not sufficiently defined, we concluded that
targeting the COX-2 signal pathway and hnRNP A2/B1 might
contribute to the synergistic anti-HCV activity of GSE. Previous
studies have also demonstrated that GSE exhibited the ability
to inhibit azoxymethane-induced colon tumorigenesis and
melanoma cell invasiveness through suppression of MAPK
and NF-κB-mediated COX-2 expression (Vaid et al., 2011;
Derry et al., 2013). Activation of the MAPK and NF-κB
signaling pathways have been shown to be associated with the
enhancement of viral replication and HCC formation (Menzel
et al., 2012; Yang et al., 2015). In Trujillo-Murillo et al. (2007)
study, the HCV genomic RNA and COX-2 were co-transfected
in Huh-7 cell and the viral RNA replication were elevated
with COX-2 induction in concentration-dependent manner.
Besides, we recently showed that suppression of COX-2 could
be a useful approach for development of HCV inhibitors
(Chen et al., 2015; Lin et al., 2015). Furthermore, COX-2
metabolite PEGs is a risk factor to develop HCC (Loginov
and Vysotskaia, 1995). Therefore, GSE could serve as a dietary
supplement to prevent HCV-related carcinogenesis by targeting
the COX-2 signaling pathway (Figure 2). Because GSE contains
various bioactive constituents, we still need to investigate
other ingredients against cellular targets that participate in
the anti-HCV response and anti-inflammatory activities of
GSE.
The viral-induced inflammation cytokines are alternative
crucial risk factors for the pathophysiology of liver diseases,
such as alcoholic hepatitis and HCV-related diabetes (Knobler
and Schattner, 2005). In addition, the aberrent production of
pathogenic pro-inflammatory cytokines and chemokines caused
by HCV infection contributes to the development of HCC
(Zampino et al., 2013). In this study, we found that GSE treatment
significantly eliminated viral-induced cytokines production, such
as COX-2, iNOS, TNF-α, and IL-1β, in either HCV protein
overexpressed or JFH-1-infected Huh-7 cells (Figure 4). In
this regard, it is notable observation against viral-induced
inflammation by GSE instead of lipopolysaccharides (LPSs),
ethanol or CCl4 -induced inflammation studies. According to the
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inhibition of MAPK and NF-kB in numerous anti-inflammation
studies of GSE, we suggested that the reductive effect of GSE
on numerous HCV-induced pro-inflammatory genes expressions
may be partly mediated via NF-κB inhibition (Figure 3).
In addition, there are also demonstrated that antioxidant
therapy may have cytoprotective effects against acute or chronic
inflammation and beneficial effects against viral hepatitis.
Previous studies demonstrated the remarkable hepatoprotective
effects of GSE in offering an enhanced antioxidant response
associated with the regulation of cell proliferation, apoptosis,
lipogenesis, fatty acids oxidation, and diabetes in liver disease
(Ray et al., 1999; Belviranli et al., 2015; Madi Almajwal and
Farouk Elsadek, 2015; Bak et al., 2016). Therefore, it is still
needed to identify whether GSE-induced antioxidant response
participating in the anti-HCV response and anti-inflammatory
activities of GSE because the compounds may possibly contain
various active constitutes. However, GSE could be administered
as a hepatoprotective supplement in combination with anti-
HCV-induced inflammatory drugs to prevent HCV-related
diseases.
In the current therapy, problem still exist in the widely
used IFN-based therapy, including an unsatisfactory curing
rate and severe side effects. Very recently, an IFN-free therapy
with a viral target’s drug also presents the possibility of drug-
resistance, which will be a major challenge of its therapeutic
effectiveness (Peter and Nelson, 2015). A combination treatment
based on different targets against viral and host genes will
possibly reduce the side effects and drug resistance, and even the
high therapeutic cost. Besides, the host targets were considered
as promising anti-viral therapy in the future. Miravirsen, an
inhibitor targeting mir-122 which interacted with HCV 5′ UTR,
is completed the enrollment in phase 2 clinical trail (Ottosen
et al., 2015). In addition, instead of viral gene products, there
are more benefits to higher barrier to viral resistance and
broader genotype specificity by targeting host cell factors with
specific anti-viral action. Targeting the host factor by GSE is
beneficial to avoid drug resistance and to sustain the viral
response because the mutation rate of the host genome is lower
than that of the RNA virus genome. In addition, targeting
host cellular factors required for six types of HCV replication
will overcome HCV quasispecies over long-term regimens.
Here, we reported that GSE can be used in combination with
anti-viral inhibitors that providing synergistic anti-HCV effects
(Table 1), and the results revealed that it is worthwhile to
further investigate the effects of GSE on preventing the escape
of mutant variants, different genotypes, and alleviating the side
effects.
Grape seed extract is rich in polyphenols and contains
mixtures of monomers, oligomers (also known as procyanidin),
and polymers of catechin and/or epicatechin, in which several
monomer catechin derivatives, including catechin, epicatechin,
(-)-epigallocatechin-3-gallate (EGCG), and quercetin, exert
FIGURE 5 | Proposed model illustrating the mechanisms of inhibition activity of GSE on HCV replication and HCV-induced inflammation response.
GSE suppresses HCV replication by down-regulating the COX-2 expression through reducing the NF-κB and MAPK/ERK/JNK signaling pathways. Moreover, GSE
significantly reduced the virus-induced inflammation response upon HCV infection or oncogenic viral protein overexpression.
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anti-HCV activity (Chen C. et al., 2012; Khachatoorian et al.,
2012; Lin et al., 2013). However, these flavonol and polyphenol
monomers are poor composed in GSE (less than 8%) and
showed much higher effective concentrations against HCV
replication (Overman et al., 2010). Otherwise, Procyanidin
B1, the main oligomers of GSE (more than 74%), has been
shown to effectively suppress HCV replication (Bentivegna and
Whitney, 2002; Li et al., 2010). Therefore, we suggested that
procyanidins are the potential active indicators of GSE against
HCV. Previous studies reported that the oligomerized grape
seed polyphenols are more conductive to absorption rate than
non-oligomerized forms (Fujii et al., 2007). It is worthwhile
to identify the bioactive oligomerized grape seed polyphenols
responsible for anti-HCV replication for the development of anti-
viral therapy. Besides, the oligomerized grape seed polyphenols
demonstrated significant anti-inflammation activity through
reducing NF-kB transactivation and JNK/ERK activation in
macrophages (Overman et al., 2010; Sakurai et al., 2010),
which is consistent with our results (Figures 3 and 4).
In the present study, we proposed the model of GSE
on anti-HCV activity by suppression of cellular COX-2
expression through the inactivation of NF-κB and ERK/JNK
MAPK signaling pathways (Figure 5). Currently, several
compounds, such as erlotinib, alisporivir, and targeting host
factor strategies are in the clinical development phase for
therapeutic HCV infection. We believe that GSE should be
considered a potential antiviral supplement that is worthy of
further investigation of anti-HCV effects using suitable animal
models.
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